Evidence map›Paper›PMID 36444361›Full record

ReviewCJC open2022

Treatment and Prevention of Cardiovascular Implantable Electronic Device (CIED) Infections.

Peter Phillips, Andrew D Krahn, Jason G Andrade, Santabhanu Chakrabarti, Christopher R Thompson, David J Harris, Jacqueline M Forman, Shahzad S Karim, Laurence D Sterns, Lynn M Fedoruk and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in CJC open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Peter PhillipsSt. Paul's Hospital, Vancouver, British Columbia, Canada.
Andrew D KrahnSt. Paul's Hospital, Vancouver, British Columbia, Canada.
Jason G AndradeSt. Paul's Hospital, Vancouver, British Columbia, Canada.
Santabhanu ChakrabartiSt. Paul's Hospital, Vancouver, British Columbia, Canada.
Christopher R ThompsonSt. Paul's Hospital, Vancouver, British Columbia, Canada.
David J HarrisSt. Paul's Hospital, Vancouver, British Columbia, Canada.
Jacqueline M FormanSt. Paul's Hospital, Vancouver, British Columbia, Canada.
Shahzad S KarimSt. Paul's Hospital, Vancouver, British Columbia, Canada.
Laurence D SternsDivision of Cardiology, University of British Columbia, Gordon & Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada.
Lynn M FedorukDivision of Cardiovascular Surgery, University of British Columbia, Gordon & Leslie Diamond Health Care Centre, Vancouver, British Columbia, Canada.
Eric PartlowDivision of Infectious Diseases, University of British Columbia, Vancouver, British Columbia, Canada.
Jamil BashirSt. Paul's Hospital, Vancouver, British Columbia, Canada.
University of British Columbia · CARoyal Columbian Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An expanded role for cardiac implantable electronic devices (CIEDs) in recent decades reflects an aging population and broader indications for devices, including both primary prevention and management of dysrhythmias. CIED infection is one of the most important device-related complications and has a major impact on mortality, quality of life, healthcare utilization, and cost. Unfortunately, the investigation and management of CIED infection remain complex, often necessitating complete and timely removal of the device and leads in order to eradicate the infection. In addition, the translation of knowledge from an extensive literature to a disparate group of medical practitioners has often been inadequate. This review of CIED infection management highlights the significant advances made during the past decade, including diagnostic criteria, advanced imaging, and next-generation sequencing for culture-negative cases or those in which uncertainty remains. We also outline the role and indication for powered lead extraction, the process of antibiotic choice and treatment duration, considerations related to the timing and location for reimplantation, and preimplantation risk stratification and associated interventions to reduce the risk of CIED infection.

Identifiers

PMID36444361
PMCPMC9700216
OpenAlexW4290989174

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.